TELA Bio (TELA) Change in Receivables (2018 - 2026)
TELA Bio's (TELA) quarterly Change in Receivables came in at -$593000.0 in Q1 2026, down 247.51% year-on-year from $402000.0 in Q1 2025, and up 36.37% quarter-over-quarter from -$932000.0 in Q4 2025.
TELA Bio (TELA) Change in Receivables (2018 - 2026) Analysis & Trends
TELA Bio's Change in Receivables history runs 9 years deep, the most recent figure standing at -$593000.0 for Q1 2026.
- On a quarterly basis, Change in Receivables fell 247.51% year-over-year to -$593000.0 in Q1 2026; TTM through Mar 2026 was -$885000.0, a 195.16% decrease from a year earlier, with the FY2025 full-year figure at $110000.0, down 85.56% from the prior year.
- Change in Receivables advanced to -$593000.0 in Q1 2026 per TELA's latest filing, from -$932000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $2.0 million in Q3 2024 and bottomed at -$983000.0 in Q4 2024.
- The 5-year median for Change in Receivables is $237000.0 (2023), against an average of $338705.9.
- Across the five-year window, Change in Receivables surged 1200.0% in 2024 and sank 247.51% in 2026, its largest moves.
- Year by year, Change in Receivables stood at $890000.0 in 2022, then jumped by 80.0% to $1.6 million in 2023, then plunged by 161.36% to -$983000.0 in 2024, then climbed by 5.19% to -$932000.0 in 2025, then soared by 36.37% to -$593000.0 in 2026.
- Per Business Quant, the three latest TELA Change in Receivables figures stand at -$593000.0 (Q1 2026), -$932000.0 (Q4 2025), and $107000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 117.90 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | -141.00 Mn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | -124.60 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | - |
| 10 | TELA Bio | 35.02 Mn | -4.52 Mn | 12.52 Mn | -593,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -593,000.00 |
| Mar 31, 2026 | -593,000.00 |
| Dec 31, 2025 | -932,000.00 |
| Dec 31, 2025 | -932,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Mar 31, 2025 | 402,000.00 |
| Mar 31, 2025 | 402,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | -497,000.00 |
| Jun 30, 2024 | -497,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |